CD4/CD8 Ratio During Human Immunodeficiency Virus Treatment: Time for Routine Monitoring?
Raquel Ron(Universidad de Alcalá), Sergio Serrano‐Villar, Elena Moreno(Instituto de Salud Carlos III), Talía Sainz(Hospital Universitario La Paz), Santiago Moreno(Universidad El Bosque), Javier Martínez‐Sanz(Instituto de Salud Carlos III), Fátima Brañas(Universidad Complutense de Madrid)
Cited by 72
Related Papers
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
|Cell|2020|1.1k
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
|Science|2021|364
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006|137